These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7350874)

  • 1. Somatostatin inhibits diarrhea in the carcinoid syndrome.
    Dharmsathaphorn K; Sherwin RS; Cataland S; Jaffe B; Dobbins J
    Ann Intern Med; 1980 Jan; 92(1):68-9. PubMed ID: 7350874
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant carcinoid tumour with gangrene of the small intestine.
    Murray-Lyon IM; Rake MO; Marshall AK; Williams R
    Br Med J; 1973 Dec; 4(5895):770-1. PubMed ID: 4758575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of somatostatin infusion in four patients with malignant carcinoid syndrome.
    Quatrini M; Basilisco G; Conte D; Bozzani A; Bardella MT; Bianchi PA
    Am J Gastroenterol; 1983 Mar; 78(3):149-51. PubMed ID: 6187212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic acidosis in patients with the carcinoid syndrome: treatment with parachlorophenylalanine.
    Feldman JM
    J Surg Oncol; 1982 Apr; 19(4):219-23. PubMed ID: 6176809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.
    Kvols LK; Moertel CG; O'Connell MJ; Schutt AJ; Rubin J; Hahn RG
    N Engl J Med; 1986 Sep; 315(11):663-6. PubMed ID: 2427948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue.
    Marsh HM; Martin JK; Kvols LK; Gracey DR; Warner MA; Warner ME; Moertel CG
    Anesthesiology; 1987 Jan; 66(1):89-91. PubMed ID: 2432806
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome.
    Davis GR; Camp RC; Raskin P; Krejs GJ
    Gastroenterology; 1980 Feb; 78(2):346-9. PubMed ID: 7350058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bronchial carcinoid and carcinoid syndrome].
    Biriukov IuV; Bassalyk LS; Kulikov LS; Men'shikov VV; Efimov BI
    Sov Med; 1970 Dec; 33(12):39-43. PubMed ID: 5516942
    [No Abstract]   [Full Text] [Related]  

  • 9. Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial.
    Pavel M; Gross DJ; Benavent M; Perros P; Srirajaskanthan R; Warner RRP; Kulke MH; Anthony LB; Kunz PL; Hörsch D; Weickert MO; Lapuerta P; Jiang W; Kassler-Taub K; Wason S; Fleming R; Fleming D; Garcia-Carbonero R
    Endocr Relat Cancer; 2018 Mar; 25(3):309-322. PubMed ID: 29330194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection and biochemical exploration of carcinoid tumors].
    Dreux C; Bousquet B; Halter D
    Nouv Presse Med; 1974 Mar; 3(11):671-6. PubMed ID: 4546018
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.
    Ruszniewski P; Ducreux M; Chayvialle JA; Blumberg J; Cloarec D; Michel H; Raymond JM; Dupas JL; Gouerou H; Jian R; Genestin E; Bernades P; Rougier P
    Gut; 1996 Aug; 39(2):279-83. PubMed ID: 8977344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary carcinoid tumor of the bilateral testis associated with carcinoid syndrome.
    Son HY; Ra SW; Jeong JO; Koh EH; Lee HI; Koh JM; Kim WB; Park JY; Shong YK; Lee KU; Kim GS; Kim MS
    Int J Urol; 2004 Nov; 11(11):1041-3. PubMed ID: 15509216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update of lanreotide acetate for treatment of adults with carcinoid syndrome.
    Guadalupe E; Deshpande HA; Stein SM
    Drugs Today (Barc); 2018 Aug; 54(8):457-465. PubMed ID: 30209440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin does not prevent serotonin release and flushing during chemoembolization of carcinoid liver metastases.
    Zimmer C; Kienbaum P; Wiesemes R; Peters J
    Anesthesiology; 2003 Apr; 98(4):1007-11. PubMed ID: 12657865
    [No Abstract]   [Full Text] [Related]  

  • 15. Functioning primary carcinoid tumor of the ovary. A light- and electron-microscopic study with review of the literature.
    Qizilbash AH; Trebilcock RG; Patterson MC; Lamont KG
    Am J Clin Pathol; 1974 Nov; 62(5):629-38. PubMed ID: 4606570
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition of pancreatic apudoma-dependent hypersecretion of gastrin, glucagon and serotonin using somatostatin-14].
    Varas Lorenzo MV
    Rev Esp Enferm Apar Dig; 1987 Oct; 72(4 Pt 1):329-33. PubMed ID: 2446363
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of salmon calcitonin on symptoms and urinary excretion of 5 hydroxyindoleacetic acid in the carcinoid syndrome.
    Antonelli A; Del Guerra P; Fierabracci A; Gori E; Baschieri L
    Br Med J (Clin Res Ed); 1987 Oct; 295(6604):961. PubMed ID: 2445410
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carcinoid syndrome of the small intestine].
    Pik A; Levy M; Gilboa Y
    Harefuah; 1969 Nov; 77(10):452-4. PubMed ID: 5397701
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current views on carcinoid and the carcinoid syndrome].
    Ryss ES
    Klin Med (Mosk); 1971 Jan; 49(1):13-9. PubMed ID: 4396993
    [No Abstract]   [Full Text] [Related]  

  • 20. Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome.
    Kulke MH; Hörsch D; Caplin ME; Anthony LB; Bergsland E; Öberg K; Welin S; Warner RR; Lombard-Bohas C; Kunz PL; Grande E; Valle JW; Fleming D; Lapuerta P; Banks P; Jackson S; Zambrowicz B; Sands AT; Pavel M
    J Clin Oncol; 2017 Jan; 35(1):14-23. PubMed ID: 27918724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.